Market Research Reports

03 juillet 2014

Human Reproductive Technologies Market Expected to Reach USD 27.1 Billion Globally in 2019: Transparency Market Research

According to a new market report “Human Reproductive Technologies Market  - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 – 2019,” the global market for human reproductive technologies was valued at USD 23.0 billion in 2012 and is expected to reach USD 27.1 billion in 2019, growing at a CAGR of 2.2% from 2013 to 2019.

Human reproductive technologies include procedures and therapies for conceiving or controlling pregnancy by means of artificial and/or semi artificial medical solutions. Lack of awareness about the reproductive deficiencies and their treatment necessity and availability has been limiting the market to explore its potential value. Therefore, awareness strategies adopted by market players with proper guidance for patients will fuel the emerging human reproductive technologies market especially the infertility treatment market. Developing regions such as the Asia-PacificLatin AmericaAfrica and Middle-East hold the maximum growth potential in the human reproductive technologies market. Some of the other factors contributing to the growth of human reproductive technologies market include delay in conceiving, lifestyle habits such as smoking, excessive alcohol consumption, increasing use of contraceptive pills and devices, and rising incidences of infertility.

Browse Global Human Reproductive Technologies Market Report with Full TOC athttp://www.transparencymarketresearch.com/human-reproductive-technologies-market.html

The infertility treatment market is characterized by the presence of many leading patented drug brands which are restraining the entry of generics and hence, creating a monopolistic situation. In addition, due to patient sentiments attached to infertility treatment procedures, risk ofno conception due to a low-quality generic drugis usually avoided. This report includes market analysis for seven major (by sales) branded formulations of infertility drugs, namely, Gonal-f, Follistim AQ, AndroGel, Testim, Viagra, Cialis and Levitra/Staxyn. Similarly, the contraceptive drugs and devices market has many drugs in the research pipeline awaiting commercialization to grab a share of this potential market. Large and well established pharmaceutical players such as Merck Serono, Merck & Co., Inc., Bayer AG, Pfizer, Inc., Actavis plc, Ferring International Center S.A. and Teva Pharmaceutical Industries Ltd. dominate the human reproductive technologies market.

The global contraceptives market was valued at USD 16.0billion in 2012 and is expected to grow at a CAGR of 5.5% from 2013 to Transparency Market Research2019. The oral contraceptive pills market lead the overall contraceptives market in 2012 in terms of revenue, mainly due to increasing population awareness through advertisements enabling patients to buy them over-the-counter. In the contraceptive devices market, male condoms formed the largest market segment owing to the increased accessibility and awareness along with their ease of use.

The infertility drugs market studied in this report include leading brands from three drug classes, namely, gonadotropins, androgens and erectile dysfunction drugs. Among these, Viagra was the largest brand by revenue in 2012 among others considered in the study due to increasing cases of erectile dysfunction in male infertility. Moreover, it has been a well-established and popular brand since its approval in 1998 by the U.S. FDA. Gonal-f in the gonadotropin class is the leading brand prescribed by majority of the infertility specialist due to better results achieved using it. For testosterone deficiency which is one of the major infertility causes in male patients, AndroGel is the blockbuster drug being preferred for the treatment. Generic manufacturers such as Watson Pharmaceuticals and Par Pharmaceuticals are expected to enter the market with their generic versions by 2015.

Among the infertility procedures, intrauterine insemination (IUI) is the most preferred treatment procedure due to its low operational cost and equal success rate compared to intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), which follow IUI in terms of preference. The simplicity of performing IUI is what attracts the healthcare professionals to prefer this procedure over others. Zygote intrafallopian transfer (ZIFT) and gamete intrafallopian transfer (GIFT) are the least popular procedures performed worldwide, accounting for about 0.1% of the total ART treatments. This is due to the higher procedural costs and complexity in performing these procedures.

North America dominated the global human reproductive technologies market in 2012 and is expected to maintain its leading market position till 2019. However, the Asia-Pacific contraceptive technologies market is estimated to grow at a faster pace (CAGR of 6.9% from 2013 to 2019) mainly to the rising awareness and acceptance of reproductive technologies in this region. Entry of large market players such as Merck Serono, Ferring International Center S.A. and Merck & Co., Inc.will also drive the market in the Asia-Pacific region.

Some of the key players in the global human reproductive technologies market include Abbott Laboratories, Bayer AG, Merck & Co., Inc., Merck Serono, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Watson Pharmaceuticals and Reckitt Benckiser.

The global human reproductive technologies market is categorized into the following segments:

Human Reproductive Technologies Market, by Infertility Drugs

  • Gonal-f (recombinant follitropin alfa)
  • Follistim AQ (follitropin beta)
  • AndroGel (testosterone)
  • Testim (testosterone)
  • Viagra (sildenafil citrate)
  • Cialis (tadalafil)
  • Levitra/Staxyn (vardenafil)

 

Browse Global Human Reproductive Technologies Market Report with Full TOC athttp://www.transparencymarketresearch.com/human-reproductive-technologies-market.html

Human Reproductive Technologies Market, by Infertility Procedures

  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Zygote Intrafallopian Transfer (ZIFT)
  • Gamete Intrafallopian Transfer (GIFT)
  • Intrauterine Insemination (IUI)

Human Reproductive Technologies Market, by Contraceptive Technologies

Drugs

  • Oral Contraceptive Pills
  • Contraceptive Injectables
  • Topical Contraceptives

Devices

  • Male Contraceptive Devices (Male Condoms)
  • Female Contraceptive Devices
    • Female Condoms
    • Diaphragms
    • Sponges
    • IUDs
      • Hormonal IUDs
      • Copper IUDs
    • Subdermal Contraceptive Implants
    • Vaginal Rings

Human Reproductive Technologies Market,by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

 

Related & Recently Published Report by Transparency Market Research

Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html

The global meningococcal vaccines market is studied on the basis of vaccine types such as polysaccharide, conjugate and combination vaccines. The vaccine types are further segmented into different brands. The report also highlights and analyzes various brands under pipeline segment, namely, Bexsero, MnB rLP2806 and NmVac-4DT. A detailed market analysis and forecast for these segments has been provided in this study, in terms of revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each meningococcal vaccine segment and brand for the forecast period 2013 to 2019, while market size estimations have been made considering 2011 and 2012 as the base years.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Browse Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Posté par tmrreport à 13:59 - - Commentaires [0] - Permalien [#]
Tags :


Clinical Trial Management System Market is expected to reach USD 1,848.5 million in 2019: Transparency Market Research

A new market report “Clinical Trial Management System Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2019,” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.

Browse Global Clinical Trial Management System  Market Report with Full TOC athttp://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

Globally, the CTMS market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries. It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing clinical trials. Integration of CTMS with HIS provides more accurate and time saving documentation, and it is also one of the major driving factor for the growth of the CTMS market. Additionally, increasing prevalence of diseases is supporting clinical trials in different regions, and increased clinical research outsourcing is playing a major role in the growth of the CTMS market. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The global CTMS market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to 2019 to reach USD 1,848.5 million in 2019.

North America is a traditional clinical trial region. The average cost of pharmaceutical research and development for a successful drug continues to increase from pre-clinical to FDA approval. Clinical trials in the U.S. have been funded and sponsored by National Institute of Health (NIH), other government agencies, academic groups, voluntary health organizations and industry. According to the U.S. National Institute of Health (Clinical Trial government registry) in 2011, there were 56,981 clinical trials conducted in the U.S.

In Europe, countries in Central and Eastern Europe provide abundant chance to life science companies for clinical development. According to Oracle Corporation, a CTMS company, the percentage of clinical trials conducted in Western Europe has decreased from 25% to 19% and in Eastern Europe, the same has increased from 10% to 13% during 2006-2010.

 

However, Asia is the fastest growing region in the clinical trial management system market. Asia has become one of the fastest-growing market for pharmaceutical products. Improved industry regulatory laws and patent expiration laws in various countries including Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia has lower cost of conducting clinical trials compared to Europe or the U.S.

Oracle Corporation, PAREXEL, Merge Healthcare and Medidata are the leading companies offering clinical research services. Other major players of clinical trial management systemmarket include BioClinica, MedNet, eClinforce, Bio-Optronics, Forte Research and DSG.

The clinical trial management system market is segmented as follows:

Clinical Trial Management System  Market , By Delivery Mode

  • Cloud based clinical trial management system
  • Web based clinical trial management system
  • On-premise clinical trial management system

Clinical Trial Management System  Market , By End user

  • Pharmaceuticals
  • Clinical Research Organizations
  • Healthcare providers

Clinical Trial Management System  Market , By Type

  • Enterprise based clinical trial management system
  • Site based clinical trial management system

Browse Global Clinical Trial Management System Market Report with Full TOC athttp://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

Clinical Trial Management System  Market , By Components

  • Software
  • Hardware
  • Services

Clinical Trial Management System  Market , by Geography

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • U.K.
    • Russia
    • Poland
  • Asia
    • China
    • South Korea
    • Taiwan
    • India
  • Rest of the World (RoW)

 

Related & Recently Published Report by Transparency Market Research

Healthcare Information System Market (Application Based – Hospital Information system, pharmacy Information System and Laboratory Information System Delivery Based – Web Based Technology, On-premise Technology and Cloud Based Technology Component Based- Hardware, Software and Services) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.transparencymarketresearch.com/healthcare-information-system.html

Healthcare information system is an extensive integrated system which captures, stores, manages and transmits information related to the health of individuals or the activities of organizations that work within the healthcare sector. Globally, increase in aging population is playing a major role in increasing the demand of healthcare information system. Older people have less regenerative abilities and are more prone to disease, syndrome and sickness. As a result, healthcare information systems market is expected to grow at a CAGR of about 7.1% during 2013 – 2019.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

Browse Medical Devices Market Research Reports with TOC @   http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Posté par tmrreport à 12:54 - - Commentaires [0] - Permalien [#]
Tags :

03 avril 2014

Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research

Albany, NY,03 April , 2014:

Transparency Market Research has announced the addition of a new market report based on Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 in addition to their comprehensive database. This industry is considered as the most well-established and attractive market for clinical applications. It is valued at USD 8.7 billion by 2019 and expected to grow at a CAGR of 11.1% from 2013 to 2019.

Molecular diagnostics is the class of diagnostic test that explores and evaluates nucleic acids or proteins at a molecular level. Our generation is furnished with some of the most realistic and innovative ideas in biotechnology which is witnessed in the form of molecular diagnostics.

Since 1990 the market for molecular diagnostics has expanded and evolved profusely. With the introduction of PCR test for HIV and Chlamydia Trachomatis/Neisseria Gonorrhoeae (CT/NG), this industry comes across as tough and a science-oriented regulator. In the primitive times, the usage of molecular diagnostics was restricted due to high cost of tests and requirement of skilled professionals. Nonetheless, this was overcome by the reduction in labor cost, cost per sample analysis, introduction and development in the advanced technologies and automation systems.

Currently, molecular diagnostics constitutes a trivial section of the overall diagnostics market, but is reckoned as the fastest growing sector across the globe. By far it is approached as the fastest growing sector of the in-vitro diagnostics market.  This is clearly supported by the fact as now-a-days, the molecular diagnostics tests are widely performed for testing infectious diseases such as HIV, HPV, HCV, HAI, cancer testing, genetic diseases, HLA testing, and many others. There are molecular diagnostic kits available for pharmacogenetics and blood donor screening testing processes too.

The first-generation amplification, fluorescent in situ hybridization (FISH), DNA probes, and second-generation biochips and micro fluidics are the technologies that comprise molecular diagnostics.

Moreover, the next-generation signal detection, molecular labels, and biosensors are handful of other influencing factors that showcases the discovery of therapeutic molecules, optimization of drug therapy, and the screening and diagnosis of patients. The next-generation sequencing is developing rapidly owing to its prompt turnaround time, low cost, reduction in cost of sequencing, high sensitivity, and convenient workflow.

Molecular diagnostics is considered as a highly evolving market due to the rise in chronic infections, increasing investments in R&D, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications of various tests. Molecular diagnostics test is placed in the fast lane development so that infectious diseases testing, oncology testing, genetic testing, blood screening, cardiovascular testing and other medical procedures are carried out promptly.

According to the current market statistics, molecular diagnostic’s major revenue is dominated by infectious diseases that standalone captures 60% of the overall molecular diagnostic applications market share. However, the remaining one third is attributed to the blood donor screening and genetic testing procedures. The growth of this sector is also seen through the rising incidences of hospital acquired infections (HAI) that is anticipated as the fastest acquiring segment within infectious diseases. It is further expected to grow at a CAGR rate of 15.1% in the forecast period of 2013-2019. Similarly, the growing incidence of cervical cancer caused due to Human Papilloma Virus (HPV) is a noteworthy contributor to the expansion of this segment. HPV testing is augmented to rise at a CAGR of 14.8% during the same forecast period of 2013-2019. In addition, the HLA typing testing and oncology testing are also projected to grow at a rapid rate during the same forecast period.

Considering the geographical status of the molecular diagnostics market, North America and Europe capture the majority of the market share due to their investments in genomics and proteomics, and rising awareness and usage of personalized medicines. The geographical share of North America and Europe for 2012 (%) in terms of molecular diagnostics market is 42.68% and 29.79%. Nevertheless, rising patient awareness towards wellness, usage of preventive medicines, access to technological advanced medical equipment and products, and wide scale economic developments are subsequently taking places across other countries in Asia-Pacific (17.47%) and RoW (Rest of the World) (10.06%) respectively.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Visit: http://de.transparencymarketresearch.com/

Visit: http://www.europlat.org/

Visit: http://semiconductor-market-reports.blogspot.com

Visit: http://www.transparencymarketresearch.com/

 

02 avril 2014

Organ Preservation Solutions Market predicted to reach USD 204.9 Million Globally in the Forecast 2013 – 2019

Transparency Market Research, In Its Latest Report Projects that the Market for Organ Preservation Solutions will post a 16.5% CAGR through 2019

Transparency Market Research announced its new report on the Organ Preservation Solutions market that was first valued at USD 0.06 billion in 2012. However, the current market value is predicted to reach USD 204.9 million by 2019 at a CAGR growth rate of 16.5% for the market revenue forecast period 2013 to 2019.

An organ preservation solution is a method of preserving the organs of the body when they are not inside the body system. It is a medically proven technique of letting the organs become vulnerable to the exterior environment outside the human body. Hence, the organs that are removed from the human body are then preserved in specific adjustments using medical solutions. Organ preservation solutions have been playing a key role in increasing the number of organ transplants. They are intended for different purposes such as organ development of biologics and drugs, and organ transplant procedures and research.

Today, the medical industry has a growing demand for organ transplants in forms of different organ types including liver and kidney too. Such aspects are likely to infuse significant demand for organ preservation solutions in the long run.

The global market for organ preservation solutions has been predicted to grow at a CAGR rate of 16.5% during the forecast period 2013 to 2019. Moreover, it is projected to reach market revenue of USD 204.9 Million in the same forecast period. The Organ preservation solutions report studies the deep insights of this market and foresights every major solution for preserving organs. Amongst the proposed solutions, Viaspan and Custodiol are together accounted for over 75% of the total market share. During this market forecast period 2013 to 2019, the Custodiol market is predicted to rise and grow at a CAGR of 17.1%. 

The organ preservation solutions market is primarily driven by the rising incidences of organ failures in the patients due to changes in lifestyles such as fast food consumption, smoking, and alcohol, and increasing number of patients who are eagerly waiting to get an organ transplant done. The market also gets its popularity due to the rise in geriatric population, particularly in the developed regions such as U.K and U.S. All these conditions and locales are likely to propel the growth of this specific market. Another major reason for this growing sector is the rise in per capita healthcare expense and the advancing imbursement setups arranged for the organ transplant procedures in nations such as U.K, U.S., as well as now in India too.

Additionally, there are interesting techniques which are implemented to preserve the organs in the appropriate spaces. These include hypothermic perfusion preservation (HPP), static cold storage (SCS), and many others. Organ preservation solutions is extensively utilized for preserving different organs such as liver and kidney as it is highly capable of preserving a variety of organs unlike solutions such as HBS and Perfadex solution. 

Unlike the SCS that does not allow any continuous contact of the organ with solution, the HPP is a much better and adaptable technique to use. It is a machine perfusion process that maintains a constant supply to the organs needed by the solution whereby, the survival duration of the organs increases accordingly. The HPP market is anticipated to grow at a CAGR of 19.2% during the forecast period 2013 to 2019.

Earlier, in 2012, the European region had been accounted for the largest share of market revenue and until the present times, it still continues to prove its growth with a rate of 49.96% for 2012 (%). This is due to the presence of a large number of voluntary organ donors in this region. Nevertheless, other countries such as North America (42.23%), Asia-Pacific (5.66%), and RoW (2.15%) help propel the growth of the organ preservation solutions market as well.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Visit: http://de.transparencymarketresearch.com/

Visit: http://www.europlat.org/

Visit: http://semiconductor-market-reports.blogspot.com

Visit: http://www.transparencymarketresearch.com/

 

Minimally Invasive Vertebral Compression Fracture Repair Market to Reach USD 2.82 billion by 2019: Transparency Market Research

Albany, New York, 26 March 2014

Transparency Market Research has announced the addition of market research report on the Minimally Invasive Vertebral Compression Fracture Repair Market titled "Minimally Invasive Vertebral Compression Fracture Repair Market (Vertebroplasty and Kyphoplasty Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019". According to the report, the global market for Vertebroplasty and Kyphoplasty Devices is estimated to reach a value of USD 2.82 billion in 2019 with a growth rate of 8.7% through the years 2013 to 2019. The value of this industry was about USD 1.58 billion in 2012.

Transparency Market Research

Vertebral compression fractures (VCFs) or spine fractures, as they are commonly called, are instances of a broken bone or cracked vertebrae in the spine. VCFs commonly occur in people having osteoporosis and low bone density. However, severe trauma such as accidents, sports injury or a hard fall and metastatic tumors are common reasons for VCFs.

Clinical symptoms of VCFs may include sudden onset of back pain, limited spinal mobility, increase in pain while standing or walking, disability and deformity of the vertebrae over time, eventual vertebral height loss and medical conditions like kyphosis, segmental instability and neurological complications.

Though nonsurgical ways of treating VCFs such as medication, exercises, bracing and bed rest are widely prevalent, surgical ways such as kyphoplasty and vertebroplasty have also evolved as valuable adjunctive treatment options. are also increasingly gaining popularity for treating complex cases where non-surgical methods fail to benefit.

Kyphoplasty involve percutaneous cannulation of the vertebral fracture by placing an inflatable bone tamp (a balloon like structure) into the fracture. This helps in restoring the original height of the vertebrae, which is then injected with bone cement. Vertebroplasty, on the other hand, involves direct percutaneous injection of bone cement on the vertebral fracture.    

Vertebroplasty helps in relieving pain and enhancing mobility in patients while Kyphoplasty also helps in restoring the height of the deformed vertebrae, thus assisting in the cure of kyphosis. Complication rates of less than 2 percent for osteoporotic VCFs and upto 10 percent for VCFs due to malignant tumors, patient testimonials of significant pain relief and rise in physical functioning along with  advancements in the technology used for treatment have all resulted in the popularity of these treatments over the past few decades.

However, a comparatively lower complication rate post procedure and additional benefits such as restoration of vertebral height have resulted in a higher adoption rate of kyphoplasty procedures over vertebroplasty throughout the world, particularly in North America. Considering this popularity of the procedure and its obvious advantages over vertebroplasty, its market share in the coming future is estimated to be increasing rapidly. In 2011, the global market for kyphoplasty was worth USD 555.4 million.

The international market of minimally invasive VCF repair is highly secure in nature. There only a handful of vendors that are well established and dominate the market by capturing over 80% of its share. The existence of only a few market players has resulted in an intensive competitive rivalry among the players.  The market is further characterized by activities such as acquisitions, long term supply agreements and partnerships. The major companies that dominate this market include Medtronic Inc., Cook Medical Inc., CareFusion Corporation, DFine, Inc., Zimmer Holdings, DePuySynthes Inc., among few others.

Owing to the early launch of innovative products and techniques in the US, it is no surprise that the country is the current market leader of the minimally invasive VCF repair market. Existence of factors such as high awareness about VCF conditions and the treatments available and a supportive economic base particularly in the form of well-defined medical re-imbursement policies has also proved instrumental in the growth of the minimally invasive VCF repair market in the US. However, developing economies such as China, Japan, India, Korea are observed as potentially emerging markets owing to the aging population, increase in general awareness about osteoporosis and development in healthcare facilities in these countries.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

Contact:

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA/Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Blog: http://www.tmrblog.com/

Blog: http://transparencymarketresearch.areavoices.com/



01 avril 2014

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research

ALBANY, New York, February 3, 2014: 

Transparency Market Research

In its latest published report titled “Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, Transparency Market Research projects that the global life sciences BPO market will register a 21.5% CAGR over the forecast period.

Browse Report With TOC : http://www.transparencymarketresearch.com/life-sciences-bpo-market.html

The latest addition to the market research report database of Transparency Market Research is a report on the dynamic Life Sciences BPO market. The new report—titled Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019—analyzes the core factors influencing this market and potential growth areas as well as restraints besides profiling leading market players in this sector.

According to the report, the global market for Life Sciences business process outsourcing (BPO) was worth USD 152.5 billion in 2012, and expert analysts from the firm predict through in-depth analyses that the market will likely be worth USD 596.0 billion by 2019, demonstrating a healthy compounded annual growth rate (CAGR) of 21.5% between 2013 and 2019.

In the recent years, several factors have collectively contributed towards creating a need for Life Sciences BPO. Among these are the increasingly complex rules that govern clinical trials, growing pressure from regulatory bodies, as well as the pressure of rising cost of inputs and R&D.

This has compelled market players to look at various alternative means that can help curtail costs without compromising their competitive edge in the market. Many players regard outsourcing as an efficient answer to these concerns, creating a burgeoning market for Life Sciences BPO services worldwide. This market has risen significantly over the past decade and there has been growing acceptance of Life Sciences BPO providers.

Furthermore, leading companies in the life sciences sector have also had to deal with patent expirations that have risen in numbers over the last few years. Not to mention the costs associated with the failure of certain drugs and products at the clinical trials stage. These are a few other factors that have spurred a demand for Life Sciences BPO services, or the pharmaceutical outsourcing services—as some refer to it.

According to the market research report that is based on data obtained from key industry players, a number of pharmaceutical and biotech firms regard outsourcing certain activities as a solution to helping these companies focus on their strategic and core functions. These companies can then engage their highly skilled resources in more productive strategies and cutting-edge projects in-house.

The market research report by Transparency Market Research discusses the existing as well as expected market share of the various segments within the Life Sciences BPO market such as the Contract Manufacturing Organizations (CMOs), which is the largest segment by size, and the Contract Research Organizations (CROs).

Furthermore, this in-depth research report also discusses the various factors that have directly or indirectly stirred a demand for generic drugs and consequently, a demand for outsourced activities as well. It also throws light on the various advantages experienced by market players via their outsourcing partners on the R&D, compliance, marketing, and productivity front. Within the CMO market, the market for API constitutes the largest segment.

Similarly, the services of CROs are regarded as being crucial to the life sciences and pharmaceutical segments in the contemporary scenario because of a myriad of factors. The report by Transparency Market Research discusses the various propellants that have led to these services being sought after (including factors such as rising costs of clinical trials, marketing costs, compliance complexities, and so on). Within the CRO market, the largest segment was that of drug discovery.

Based on various analyses, the report also anticipates that the market for clinical data management services outsourcing is likely to witness the highest rate of growth, pegged at 17.3%, between 2013 and 2019.

The market research report then goes on to dissect the global Life Sciences BPO market based on geography, by market share as well as revenue. It predicts that the highest growth within this sector will be observed in the Asia-Pacific region over the forecast period, owing to a number of favorable factors.

To purchase the report or to browse through the entire ToC, please visit www.transparencymarketresearch.com.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA/Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/

Blog: http://marketsize.blog.fc2.com/

http://globalmarketresearchreports.quora.com/

http://seekingalpha.com/user/16370542/instablog

28 mars 2014

Nanomedicine Market: An Overview of Growth Factors and Future Prospects

Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.

Nanomedicine is based on the utilization of knowledge pertaining to various nanoparticles, their medical usages, and their actions within the human body.

There still exists considerable scope for research in this domain, and scientists are currently engaged in further studying the treatment-worthiness of a number of nanoparticles such as fullerenes, dendrimers, drug conjugates, and nano crystals.

It is important to note that this area of medicine is still in its nascent stage mainly because it is a niche research area and it receives comparatively less research funding.

Future prospects of the nanomedicine market

A research report by Transparency Market Research, a U.S.-based market research company, projects that the nanomedicine market will be largely driven by partnerships between global research firms and leading industry institutes. These collaborations will play a crucial part in attracting more investments. The report states that the global market for nanomedicine is projected to witness a compounded annual growth rate (CAGR) of 12.3% between 2013 and 2019.

Oncology – a significant segment within the nanomedicine market

According to the market research report by Transparency Market Research, oncology was the largest application segment within the nanomedicine market with a total share of 38%. This is attributed to the large scale focus on developing drugs and treatments for cancer, and the fact that approved nanomedicine drugs also exist in the market.

However, cardiovascular applications of nanomedicine are regarded as being the fastest-growing segment within the nanomedicine market. A large number of people being affected by cardiovascular problems worldwide, and the availability of various devices catering to the needs of this patient segment are growth influencers in this market.

In addition, there has been a perceptible increase in support from various governments in bolstering research as well as product approvals within the nanomedicine segment; with this support likely to continue, the market for nanomedicine will continue to grow.

The need for research, investment and collaboration in the nanomedicine market

In the coming years, it is expected that further collaborations between academic institutes as well as research firms will provided a much-needed boost to the role of nanomedicine in chronic disease treatment.

Research and breakthroughs could lead to the emergence of new treatments and technologies, with more bioavailability.

Other factors such as a growing demand and acceptance of targeted drug delivery (especially where neurological disorders are concerned) has created a larger market for nanomedicine.

On the other hand, the prevalence of cardiovascular diseases is on the rise, and this trend asks for the introduction of drugs that possess higher efficiency and better therapeutic properties. This is yet another need that will propel demand for nanomedicine products.

Nanomedicine has already met with some success in oncology, and researchers and market players alike are buoyed by this success. Having realized the efficacy of nanomedicine in oncology, it is likely that the interest shown by market players to commercialize products in this segment will only rise.

It is projected that cardiovascular treatments are likely to emerge as the fastest growing market within the nanomedicine market between 2013 and 2019.

Increased collaboration between academic and research institutes will prove favorable for the nanomedicine market. A noteworthy example of this would be the collaboration between Elan Corporation Plc and Abbott Laboratories for the development of the Tricor drug. This collaboration was key to helping both players lower cost associated with research and development.

Looking forward, market analysts expect that breakthroughs in nanomedicine will be crucial to the development of treatments and products for diseases such as diabetes, cancer, neurological disorders, and cardiovascular diseases.

 

http://www.transparencymarketresearch.com/nanomedicine-market.html

Posté par tmrreport à 12:44 - - Commentaires [0] - Permalien [#]
Tags : ,

26 mars 2014

Global Flexible Packaging Market is Expected to Reach USD 99.10 Billion in 2019: Transparency Market Research

Transparency Market Research has launched a new market report titled “Flexible Packaging (Plastic, Paper, Aluminum Foil and Others) Market for Food & Beverages, Retail Non-Food, Pharmaceutical and Other Applications – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the global demand for flexible packaging was valued at USD 73.56 billion in 2012 and is expected to reach USD 99.10 billion in 2019, growing at a CAGR of 4.4% from 2013 to 2019. In terms of volume, the demand was 18,666.0 kilo tons in 2012 and is expected to be 24,728.7 kilo tons in 2019, growing at a CAGR of 4.1% from 2013 to 2019.

Browse Global Flexible Packaging Market Report with Full TOC athttp://www.transparencymarketresearch.com/flexible-packaging-industry.html

Increasing demand for flexible packaging in the healthcare industry is expected to be one of the key factors driving growth of the flexible packaging market. In addition, expansion of the food & beverages market, which is the largest application of flexible packaging, is expected to fuel the growth of the market. Furthermore, rising consumer preference towards light weight, durable and highly aesthetic flexible packaging is expected to significantly fuel the growth of the market over the next few years. However, volatility in the prices of crude oil which consequently affects the prices of its downstream chemicals is expected to hamper the packaging market adversely. Focused research and development activities on flexible packaging technologies have opened opportunities for the usage of nanotechnology in the formation of films and printing.

Transparency Market Research

Plastics have been extensively used in flexible packaging due to their high barrier properties, cost effectiveness and durability and accounted for over 70% of the market share in 2012. However, growing consumer demand for biodegradable packaging material due to rising awareness regarding ecology conservation is expected is boost the demand for cellulose over the next six years. In addition, cellulose has been popular than other packaging materials due to its high durability, protection from external environmental factors such as sunlight and high aesthetic value. These factors are expected to contribute significantly to the growing demand for cellulose.

Demand for flexible packaging was highest from the food & beverages sector. Several regulations are being introduced and implemented across the world regarding packaging of pharmaceuticals due to various factors such as maintenance of hygiene, reduction of fraudulent drugs in the retail market and to retain the medicinal properties of the drug. Thus, flexible packaging is expected to witness the fastest growth in pharmaceutical within the forecast period and is expected to be valued at USD 11.09 billion in 2019.

Asia Pacific accounted for the highest demand in 2012, and is expected to be fastest growing region, rising at a CAGR of 4.4% from 2013 to 2019. This trend is expected to continue over the forecast period on account of rapid economic development in this region resulting in the growth of various industries such as food & beverages, personal care products and pharmaceuticals among others. Regions present in rest of the world are expected to witness a significant increase in consumption of packaging owing to economic development in countries such as Brazil.

The report gives a comprehensive view of the flexible packaging market in terms of volume and revenue. In addition, the report includes current demand analysis and forecast for each product and application in North America, Europe, Asia Pacific and Rest of the World. The report comprises of the following segments:

Flexible Packaging Market: Product Segment Analysis

  • Plastics
  • Paper
  • Aluminum foil
  • Cellulose

Flexible Packaging Market: Application Analysis

  • Food & Beverage
  • Retail non-food
  • Pharmaceutical
  • Others

Flexible Packaging Market: Regional Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Related Published Report : 

Construction Paints and Coatings (High Solids/Radiation Cured, Powder Coatings, Water Borne Coatings, Solvent Borne Coatings, and Others) Market For Architectural Paints and Other (Special Purpose Coatings, etc.) Applications – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

http://www.transparencymarketresearch.com/construction-paints-coatings-market.html

The demand for construction paints and coatings is mainly prompted by growing infrastructure activities globally and the growing demand for water borne paints and coatings. Asia Pacific dominates the global market for construction paints and coatings. This report by Transparency Market Research analyses, estimates and forecasts the construction paints and coatings demand on a global and regional level for a six year period from 2013 to 2019, both in terms of volume and revenue. The study also provides information on restraints, drivers and opportunities along with the impact on the overall market for the forecast period. The report segments the market based on application and region and offers estimates and forecast of the construction paints and coatings market for each segment. 

The study analyses the product value chain beginning with feed stock material up to end-use. In addition, it also evaluates the market based on Porter’s five forces model that analyses the degree of competition in the market by considering factors such as the bargaining power of buyers and suppliers, threat from substitute products and new entrants. The report includes a detailed competitive landscape of the construction paints and coatings market, including company market share analysis and the profile of key market participants.
 
The report provides a decisive view on the construction paints and coatings market by segmenting the market based on product types and applications. Product segments analyzed in this report include High solids/radiation cured, Powder coatings, water borne coatings, solvent borne coatings and others (Specialty coatings). Based on applications, construction paints and coatings are segmented into architectural paints and others (Special purpose coatings, etc.). All application segments have been analyzed based on present and future trends and the market is estimated from 2013 to 2019.

 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

Blogs :

http://marketsize.blog.fc2.com/

http://globalmarketresearchreports.quora.com/

https://udallas.academia.edu/transparencymarketresearch

Contact us :

Sheela AK

90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/

Browse all Chemical & Materials Market Research Reports @ http://www.transparencymarketresearch.com/chemical-market-reports-2.html

03 janvier 2014

Teleradiology Market Is Expected to Reach USD 3.78 Billion Globally in 2019: Transparency Market Research

Medical_Devices

Transparency Market Research is Published new Market Report "Teleradiology Market (X-ray, Ultrasound, CT, MRI and Nuclear Imaging) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," The global teleradiology market was valued at USD 0.92 billion in 2012 and is expected to grow at a CAGR of 22.3% from 2013 to 2019, to reach an estimated value of USD 3.78billion in 2019.

Teleradiology encompasses the electronic transmission of radiography images from a remote location to an urban healthcare set up via internet technology. Teleradiology tends to bridge the gap between the imbalanced demand and supply of radiologists and diagnostic services across the globe. Efficient image transfer demands three major components namely image capture and sending station followed by telecommunication channels (such as internet) and lastly, image receiving station. Initially, the image transfer process was undoubtedly tedious and time consuming coupled with no assurance of image clarity and quality.Presently, teleradiology industry is witnessing the rapid evolution of image processing and transmission tools and technologies.

Presence of avant-garde radiology equipment coupled with hi-tech transmission channels and new age software's have rendered speed and accuracy to the process. Also, with the increased implementation of PACS, Radiology Information System (RIS), etc. has further favored the production of immediate yet accurate reports to the concerned physician/clinician/surgeon. The burgeoning demand for qualified radiologists, constant technological innovations followed by improved healthcare awareness are some of the major factors that encourage the growth and acceptance of global teleradiology technologies and services. Also, increasing sophistication in medical imaging platforms along with increasing rate of imaging utilization will further drive the development and evolution of teleradiology trends spread across geographies.

Global teleradiology market can be analyzed by four major geographical locations namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). These geographical locations are further evaluated on the basis of the type of imaging modalities being used such as x-ray, ultrasound, computerized tomography (CT) and nuclear imaging.Of these modalities, evolution of x-ray teleradiology has been commendable as compared to other imaging modalities majorly due to low cost, less turnaround time and high level of healthcare awareness.The other lucrative modalities constitute CT, Ultrasound and MRI teleradiology during the forecast period from 2013 to 2019. Consistent technologica upgradations of medical imaging equipment followed by improved healthcare informatics enhances the acceptance level of teleradiology technologies and services.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/teleradiology-technology-Market.html

At a regional level, North America was the largest market in 2012 for teleradiology, followed by the European region. This is attributed to rapid technological innovations, large consumer base and high disposable income. Also, presence of well-equipped healthcare institutions along with ready acceptance of novel approaches in medicine will lead to rapid growth and development of teleradiology practices in the above mentioned markets. Asia-Pacific and RoW regions are anticipated to exhibit commendable growth by 2019 due to exhaustive teleradiology service offerings, geographical location advantage and increasing healthcare expenditure in these regions.

Teleradiology market is witnessing constant market consolidation owing to increasing demand for radiologists worldwide coupled with introduction of advanced internet technologies and healthcare informatics. Some of the players of the market include Virtual Radiologic, LLC, Teleradiology Technologies, Stat Rad, Sectra ABand Radisphere National Radiology Group, Inc. are some of the teleradiology service providers.

The global teleradiologymarket is segmented as follows:

Global Teleradiology Market, by Modalities

  • X-ray
  • Ultrasound
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging

Global Teleradiology Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

 

Related & Recently Published Reports by Transparency Market Research

24 décembre 2013

Global Polyacrylamide Market is Expected to Reach USD 6.91 Billion by 2019: Transparency Market Research

Chemical_material

Transparency Market Research is Published new Market Report “Polyacrylamide (Non-ionic, Cationic, Anionic, and Others) Market for Water Treatment, Petroleum, Paper Making and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019," which observes that the polyacrylamide demand in 2012 was worth USD 3.95 billion and is expected to reach USD 6.91 billion by 2019, growing at a CAGR of 8.4% from 2013 to 2019. In terms of volume, the demand for polyacrylamide was 1,337.5 kilo tons in 2012 and is expected to cross 2,204.5 kilo tons by 2019, growing at a CAGR of 7.4% from 2013 to 2019.

Source : http://www.transparencymarketresearch.com/polyacrylamide-market.html

Polyacrylamide is an important polymer having various end user applications. Key raw materials used in the production of polyacrylamide are acrylamide copolymers and catalysts. The growing environmental concerns regarding both industrial and municipal waste water as well as rapid economic growth in Asia Pacific is expected to remain the major driving force for the polyacrylamide market. Volatile raw material prices are expected to be a key challenge for market participants.

Anionic and cationic were the predominant polyacrylamide product segments, accounting for over 70% of total demand in 2012. Due to its ionic characteristics polyacrylamide is used in various waste water treatment applications. Polyacrylamide used in petroleum applications is anticipated to be the major growth market over the next few years. Growing mining activities across the globe are anticipated to increase the demand for polyacrylamide used in mining. Similar surge in demand is expected to be witnessed from shale gas extraction facilities where polyacrylamide is used as a friction reducer for economical oil recovery.

Asia Pacific accounted for 49% of the total polyacrylamide market in 2012, followed by Europe and North America. Asia Pacific is also expected to be the fastest growing regional market in terms of both polyacrylamide consumption and production. This can be attributed to the growing economies in this region. Skilled labor, cheap availability of raw materials, equipments, and land has resulted in Asia Pacific emerging as a key destination for polyacrylamide producers. Recently various manufacturers have concentrated on capacity expansion in Asia Pacific to increase their production capacities. Europe is the other major region where polyacrylamide consumption was very strong and is expected to grow in demand with a CAGR of about 6.6% in terms of volume from 2013 and 2019.

SNF, BASF SE, Kemira, PetroChina and Beijing Hengju Chemicals are some of the major participants in the polyacrylamide industry.

Polyacrylamide Market, by Product Segment:

  • Non-ionic
  • Cationic
  • Anionic
  • Others (Homopolymers, copolymers, etc.)

Polyacrylamide Market, by Application:

  • Water treatment
  • Petroleum
  • Paper making
  • Others (Chemical, bio-medical, etc.)

Polyacrylamide Market, by Region:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world (South America, Middle East and Africa

 

Table of Content

Chapter 1 Preface

1.1 Report Description

1.2 Market segmentation

1.3 Research scope

      1.3.1 Assumptions

1.4 Research Methodology

 

Chapter 2 Executive Summary

2.1 Global polyacrylamide market, 2012–2019 (Kilo Tons) (USD Million) 

2.2 Global polyacrylamide market snapshot, 2012–2019

 

Chapter 3 Polyacrylamide - Industry Analysis

3.1 Introduction

3.2 Value chain analysis

      3.2.1 Value chain analysis of global polyacrylamide market

3.3 Market drivers

      3.3.1 Drivers for polyacrylamide market: Impact analysis

      3.3.2 Increasing environmental pressure for wastewater treatment

               3.3.2.1 Global water and wastewater treatment: Industrial and municipal market, 2012–2019 (USD Billion) 

      3.3.3 Growing market for coagulants and flocculants

      3.3.4 Global coagulant and flocculants market, 2012–2019 (USD Million) 

      3.3.5 Rapid growth in shale gas and wet shale gas production

      3.3.6 Global shale gas market, 2012–2019 (Bcf) (USD Billion) 

      3.3.7 Growing mining activities

              3.3.7.1 Global mine investments by region – project pipeline, 2011 (USD Billion) 

      3.3.8 Market restraints

              3.3.8.1 Restraints for polyacrylamide market: Impact analysis

      3.3.9 Regulations on acrylamide

      3.3.10 Volatility of raw material prices

      3.3.11 Global crude oil prices, 2008–2013  (USD/Barrel) 

 

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/polyacrylamide-market.html

 

Posté par tmrreport à 12:58 - Commentaires [0] - Permalien [#]
Tags : , ,



Fin »